Drug Topics May 2019

Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo

Studies indicate a lack of deprescribing is causing physical and fiscal pain to patients. 

Pete Kreckel discusses how he is always working to improve the workflow in his pharmacy. 

Some of the most notorious hacks during the past few years have been, and most likely will continue to be, perpetrated by a shadowy group of computer wizards known as Anonymous.

With tight margins, DIR fees, generic effective rate fees, and the delay in receiving third-party reimbursements, it’s easy to find yourself faced with cash flow pressures.

Despite legal restrictions and insufficient regulation, the market for CBD oil is booming. 

How pipeline promises-and disappointments-are impacting patients with diabetes.

A look at common HIPAA mistakes in pharmacies and how to avoid them. 

Brian McCullough, PharmD, BCPS, of Husson University notes some common mistakes pharmacists make with patient privacy and offers some ways to fix them.

As the U.S. opioid addiction crisis continues to worsen, the pharmacy industry’s role in addressing the epidemic continues to increase.

Specialty pharmacy prescriptions are plagued by a myraid of complications.

Growth is seen in healthcare settings, but still dominated by independent locations.

Is the look of your pharmacy an impediment to your success?

Progressive Ohio law adds pharmacists as a key patient care team member.

Approved regulations allow for some flexibility for drugs that can be redistributed or qualify for manufacturer credit. 

Walgreens is partnering with VillageMD to create primary care clinics in Texas

Reimbursement reform tops list of priorities, from DIR fees to rebates.

Consumers are using test strips that might lead to inaccurate results. 

The chain will use Shipt to deliver prescriptions from 6,000 locations. 

New report highlights the dangers of prescription medications beyond opioids. 

The program increased hypertension management rates to 77% in 2017. 

Tom Kraus to bring expeirence in government and industry.